vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $27.6M, roughly 1.1× Maison Solutions Inc.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -32.1%, a 14.1% gap on every dollar of revenue. On growth, LIFECORE BIOMEDICAL, INC. \DE\ posted the faster year-over-year revenue change (-4.5% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
LFCR vs MSS — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $27.6M |
| Net Profit | $-10.0M | $-5.0M |
| Gross Margin | 25.0% | 23.4% |
| Operating Margin | -9.9% | -4.9% |
| Net Margin | -32.1% | -18.0% |
| Revenue YoY | -4.5% | -10.9% |
| Net Profit YoY | -52.0% | -1840.5% |
| EPS (diluted) | $-0.29 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $27.6M | ||
| Q3 25 | $31.1M | $27.2M | ||
| Q2 25 | — | $34.4M | ||
| Q1 25 | $35.2M | $32.3M | ||
| Q4 24 | $32.6M | $29.4M | ||
| Q3 24 | $24.7M | $28.2M | ||
| Q2 24 | — | $16.9M | ||
| Q1 24 | $35.7M | $13.6M |
| Q4 25 | — | $-5.0M | ||
| Q3 25 | $-10.0M | $-1.5M | ||
| Q2 25 | — | $-287.4K | ||
| Q1 25 | $-14.8M | $1.0M | ||
| Q4 24 | $-6.6M | $-256.0K | ||
| Q3 24 | $-16.2M | $700.9K | ||
| Q2 24 | — | $-2.8M | ||
| Q1 24 | $15.6M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | 25.0% | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | 28.0% | 21.8% | ||
| Q4 24 | 34.0% | 26.9% | ||
| Q3 24 | 21.8% | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | 33.3% | 23.4% |
| Q4 25 | — | -4.9% | ||
| Q3 25 | -9.9% | 0.7% | ||
| Q2 25 | — | -15.9% | ||
| Q1 25 | -25.7% | 3.7% | ||
| Q4 24 | -6.0% | 3.2% | ||
| Q3 24 | -46.9% | 7.3% | ||
| Q2 24 | — | -14.4% | ||
| Q1 24 | -2.5% | -2.3% |
| Q4 25 | — | -18.0% | ||
| Q3 25 | -32.1% | -5.7% | ||
| Q2 25 | — | -0.8% | ||
| Q1 25 | -42.0% | 3.1% | ||
| Q4 24 | -20.2% | -0.9% | ||
| Q3 24 | -65.7% | 2.5% | ||
| Q2 24 | — | -16.4% | ||
| Q1 24 | 43.8% | -4.0% |
| Q4 25 | — | $-0.23 | ||
| Q3 25 | $-0.29 | $-0.08 | ||
| Q2 25 | — | $-0.02 | ||
| Q1 25 | $-0.47 | $0.06 | ||
| Q4 24 | $-0.25 | $-0.01 | ||
| Q3 24 | $-0.53 | $0.04 | ||
| Q2 24 | — | $-0.16 | ||
| Q1 24 | $0.42 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | $2.6M |
| Stockholders' EquityBook value | $-10.5M | $11.6M |
| Total Assets | $235.2M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | $1.1M | ||
| Q2 25 | — | $775.4K | ||
| Q1 25 | $5.4M | $445.4K | ||
| Q4 24 | $9.5M | $355.7K | ||
| Q3 24 | — | $588.9K | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | $136.0M | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | $97.1M | $2.6M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | $-10.5M | $10.1M | ||
| Q2 25 | — | $11.7M | ||
| Q1 25 | $2.2M | $12.0M | ||
| Q4 24 | $15.4M | $10.9M | ||
| Q3 24 | $-3.9M | $11.2M | ||
| Q2 24 | — | $10.5M | ||
| Q1 24 | $17.7M | $13.3M |
| Q4 25 | — | $75.4M | ||
| Q3 25 | $235.2M | $73.3M | ||
| Q2 25 | — | $77.4M | ||
| Q1 25 | $237.7M | $82.7M | ||
| Q4 24 | $255.4M | $82.7M | ||
| Q3 24 | $246.8M | $82.1M | ||
| Q2 24 | — | $82.4M | ||
| Q1 24 | $246.2M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | 5.49× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $-1.7M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $1.8M | $1.1M | ||
| Q2 25 | — | $-1.6M | ||
| Q1 25 | $1.2M | $1.7M | ||
| Q4 24 | $-6.1M | $1.1M | ||
| Q3 24 | $-613.0K | $3.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-1.4M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
